Talecris Biotherapeutics , Nasdaq: TLCR
Former Bayer maker of plasma-derived protein therapies LBO'd by Cerberus.
Industry: Health Care
First Day Return: +11.3%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 07/27/2007 |
| Offer Price | $19.00 |
| Price Range $18.00 - $20.00 | |
| Offer Shares (mm) | 50.0 |
| Deal Size ($mm) | $950 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 09/30/2009 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $950 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Research Triangle Park, NC, United States |
| Founded | 1995 |
| Employees at IPO | 3,472 |
| Website www.talecris.com | |
Talecris Biotherapeutics (TLCR) Performance
